Who We Are

MHRA Phase 1 Supplementary Accreditation

HMR was the first phase 1 unit in the UK to pass the MHRA inspection for Standard and Supplementary Accreditation. So, we’re approved for the conduct of trials of IMPs that need review by the MHRA Expert Advisory Group. Early accreditation is a tribute to our fierce commitment to quality and safety in everything we do, and confirms our status as one of the leading clinical pharmacology units in Europe.

Of course, most IMPs don’t need review by EAG – but it’s reassuring for our sponsors to know that we’re accredited for all types of IMP and for the widest possible range of trials.

Click here to view our accreditation certificate.

Back to list
National Training AwardsCyber EssentialsDigital XRaidA proud member of UK BioIndustry Associationone nucleus